Astrazeneca PLC Profile

Performance

   

Odds of Distress

25%25%
Check how we calculate scores
Equity ratings for Astrazeneca PLC are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting June 19, 2019 and ending today August 18, 2019. Click here to learn more.
44.34
USD 0.16  0.36%

Astrazeneca PLC Summary

Astrazeneca PLC (AZN) is traded on BATS Exchange in USA. It is located in 1 Francis Crick Avenue and employs 64,400 people. Astrazeneca PLC is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with total capitalization of 114.79B. Astrazeneca PLC runs under Healthcare sector within Drug Manufacturers - Major industry. The entity has 2.62B outstanding shares of which 14.29M shares are presently shorted by investors with about 4.99 days to cover shorted positions. ASTRAZENECA PLC A has about 6.25B in cash with 5.46B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.38.
Check Astrazeneca PLC Probability Of Bankruptcy

Ownership Allocation (%)

Astrazeneca PLC Target Price Odds Analysis

Odds Below 44.34HorizonTargetOdds Above 44.34
91.71%30 days 44.34 8.17%
Based on normal probability distribution, the odds of Astrazeneca PLC to move above current price in 30 days from now is about 8.17% (This Astrazeneca PLC probability density function shows the probability of Astrazeneca PLC Stock to fall within a particular range of prices over 30 days) .

Astrazeneca PLC Top Holders

Astrazeneca PLC Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Wellington Management Group LlpCommon Shares66.6 M2.8 B
Primecap Management CoCommon Shares58 M2.4 B
View Astrazeneca PLC Diagnostics

Astrazeneca PLC Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Astrazeneca PLC Key Fundamentals

Astrazeneca PLC Against Markets

Astrazeneca PLC Vital Trading Data

AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom. Astrazeneca PLC operates under Drug Manufacturers - Major classification in USA and is traded on BATS Exchange. It employs 64400 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Astrazeneca PLC SEC Filings
Astrazeneca PLC SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameAstrazeneca PLC
CEOPascal SoriotView All
Thematic Classifications
Active Investing Ideas
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Specialization
Healthcare, Drug Manufacturers - Major
InstrumentUSA Stock View All
RegionEurope
LocationUnited Kingdom
Business Address1 Francis Crick Avenue
Foreign Associates
ExchangeBATS Exchange
CIK Number0000901832
CUSIP046353108
SectorHealthcare
IndustryDrug Manufacturers - Major
BenchmarkDOW
Websitewww.astrazeneca.com
Phone44 20 3749 5000
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterJune 30, 2019
Last Fiscal Year EndDecember 31, 2018
Date Short InterestJuly 31, 2019

Astrazeneca PLC Distributions to stockholders

Astrazeneca PLC Corporate Directors

Marc Dunoyer CFO and Executive Director
Sherilyn McCoy Non-Executive Director
Genevieve Berger Non-Executive Director
Check also Trending Equities. Please also try Equity Search module to search for activelly-traded equities including funds and etfs from over 30 global markets.
Search macroaxis.com